» Articles » PMID: 38005266

A Bioinformatic Study on the Potential Anti-Vitiligo Activity of a Compound

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2023 Nov 25
PMID 38005266
Authors
Affiliations
Soon will be listed here.
Abstract

The plant has traditionally been known for its wide applications in diseases, especially vitiligo, which is characterized by patches and white macules caused by the loss of melanocytes. One of the chemical treatments for vitiligo consists mainly of skin repigmentation and usually leads to a non-durable effect by inhibiting the Janus kinase (JAK) signal transduction (STAT pathway). JAK inhibitors generally block multiple JAK tyrosine kinases, which leads to secondary effects. In this study, natural molecules from were extracted and tested using a structure-based drug-design approach and pharmacophore modeling. The best-fit candidate from the extracted molecules was compared to the chemical molecules used. The results indicated a similarity between the chemical and natural ligands which suggested the potential use of the natural product against vitiligo. The main finding of this research work was the discovery of a new molecule extracted from a natural plant and the detection of its anti-vitiligo activity using an in-silico approach. This method can significantly reduce the cost of searching for potential medicinal molecules.

References
1.
Hafsa J, Hammi K, Khedher M, Smach M, Charfeddine B, Limem K . Inhibition of protein glycation, antioxidant and antiproliferative activities of Carpobrotus edulis extracts. Biomed Pharmacother. 2016; 84:1496-1503. DOI: 10.1016/j.biopha.2016.11.046. View

2.
Cravotto C, Fabiano-Tixier A, Claux O, Abert-Vian M, Tabasso S, Cravotto G . Towards Substitution of Hexane as Extraction Solvent of Food Products and Ingredients with No Regrets. Foods. 2022; 11(21). PMC: 9655691. DOI: 10.3390/foods11213412. View

3.
Lipinski C, Lombardo F, Dominy B, Feeney P . Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001; 46(1-3):3-26. DOI: 10.1016/s0169-409x(00)00129-0. View

4.
Moya E, Bruinsma R, Kelly K, Feldman S . How suitable are JAK inhibitors in treating the inflammatory component in patients with alopecia areata and vitiligo?. Expert Rev Clin Immunol. 2022; 18(3):189-191. DOI: 10.1080/1744666X.2022.2036607. View

5.
Harris J, Harris T, Weninger W, Wherry E, Hunter C, Turka L . A mouse model of vitiligo with focused epidermal depigmentation requires IFN-γ for autoreactive CD8⁺ T-cell accumulation in the skin. J Invest Dermatol. 2012; 132(7):1869-76. PMC: 3343174. DOI: 10.1038/jid.2011.463. View